Indication

Squamous cell carcinoma of vulva

Squamous cell carcinoma of the vulva is an invasive epithelial malignancy arising from the stratified squamous epithelium of the female external genitalia, predominantly affecting the labia majora and labia minora. Read more about Squamous cell carcinoma of vulva

12 drugs 12 manufacturers

Advertisement

Drugs that treat it

Common Squamous cell carcinoma of vulva therapies.

Showing 1–9 of 12 drugs

Filter & compare in the drug finder →Opens the drug finder with Squamous cell carcinoma of vulva preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Squamous cell carcinoma of vulva.

Squamous cell carcinoma of the vulva is an invasive epithelial malignancy arising from the stratified squamous epithelium of the female external genitalia, predominantly affecting the labia majora and labia minora.

It represents the vast majority of vulvar cancers and typically affects postmenopausal individuals, though it also occurs in younger populations.

Pathophysiologically, the disease develops through two main pathways: a human papillomavirus (HPV)–dependent route driven by persistent high-risk HPV infection, or an HPV-independent route commonly associated with chronic inflammatory dermatoses, such as lichen sclerosus, and frequent TP53 mutations.

Clinically, it typically presents with persistent vulvar pruritus, pain, ulceration, or a visible exophytic or nodular mass that may bleed or cause localized discharge.

Personalize your experience

Follow Squamous cell carcinoma of vulva and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it